Fecal Incontinence

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Carbon Biosciences
Carbon BiosciencesMA - Waltham
1 program
1
Durasphere FIPhase 21 trial
Active Trials
NCT00762047TerminatedEst. Jun 2009
C
ColoplastAustralia - Mulgrave
1 program
Fecal Incontinence Management SystemN/A1 trial
Active Trials
NCT00556972TerminatedEst. Apr 2008
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
NASHA/DxN/A1 trial
Active Trials
NCT00605826CompletedEst. Nov 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Carbon BiosciencesDurasphere FI
ColoplastFecal Incontinence Management System
Bausch HealthNASHA/Dx

Clinical Trials (3)

NCT00762047Carbon BiosciencesDurasphere FI

A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence

Start: Jun 2004Est. completion: Jun 2009
Phase 2Terminated
NCT00556972ColoplastFecal Incontinence Management System

A Feasibility Study of a Fecal Incontinence Management System for Medical Use

Start: Jan 2008Est. completion: Apr 2008
N/ATerminated
NCT00605826Bausch HealthNASHA/Dx

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

Start: Sep 2006Est. completion: Nov 2009
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space